AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33593675 — intervention group
Group type: COMPARATOR
Intervention: Conventional custom open trays
Number of subjects: 22
Study 34742230 — intervention group
Group type: EXPERIMENTAL
Intervention: LTN 200 mg
Number of subjects: 1471
Study 34742230 — intervention group
Group type: EXPERIMENTAL
Intervention: LTN 100 mg
Number of subjects: 1471
Study 34742230 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1471
Study 34742230 — intervention group
Group type: EXPERIMENTAL
Intervention: LTN 200 mg, LTN 100 mg, LTN 50 mg
Number of subjects: 1471
Study 35414799 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotics combined with standard triple therapy (Group B)
Number of subjects: 96
Study 35414799 — intervention group
Group type: COMPARATOR
Intervention: Standard triple therapy (Group A)
Number of subjects: 96
Study 35414799 — intervention group
Group type: EXPERIMENTAL
Intervention: Gastrointestinal X-ray imaging based on intelligent algorithm
Number of subjects: 96
Study 35414799 — intervention group
Group type: EXPERIMENTAL
Intervention: HP-positive patients
Number of subjects: 96
Study 35414799 — intervention group
Group type: EXPERIMENTAL
Intervention: HP-negative patients
Number of subjects: 96
Study 34318441 — intervention group
Group type: EXPERIMENTAL
Intervention: Norovirus GI strains
Number of subjects: 100
Study 34318441 — intervention group
Group type: EXPERIMENTAL
Intervention: HAdV
Number of subjects: 100
Study 34318441 — intervention group
Group type: EXPERIMENTAL
Intervention: Both viruses (norovirus and HAdV)
Number of subjects: 100
Study 34318441 — intervention group
Group type: EXPERIMENTAL
Intervention: Viral concentrations
Number of subjects: 100
Study 34318441 — intervention group
Group type: EXPERIMENTAL
Intervention: Murine norovirus 1 (internal process control)
Number of subjects: 100
Study 34318441 — intervention group
Group type: EXPERIMENTAL
Intervention: Seasonal positivity rate
Number of subjects: 100
Study 34318441 — intervention group
Group type: EXPERIMENTAL
Intervention: HAdV and fecal coliform counts
Number of subjects: 100
Study 35392832 — intervention group
Group type: EXPERIMENTAL
Intervention: Staged Integral Art-based Cognitive Intervention (SIACI) program, 16-week, 24-session
Number of subjects: 88
Study 35392832 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group (receives SIACI after follow-up assessment)
Number of subjects: 88
Study 32955693 — intervention group
Group type: EXPERIMENTAL
Intervention: Feedback intervention by letter
Number of subjects: 1003
Study 32955693 — intervention group
Group type: EXPERIMENTAL
Intervention: Feedback intervention by telephone
Number of subjects: 1003
Study 32955693 — intervention group
Group type: COMPARATOR
Intervention: No-contact control condition
Number of subjects: 1003
Study 32001256 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-Beall, DOAJ journals
Number of subjects: 410
Study 32001256 — intervention group
Group type: COMPARATOR
Intervention: Beall journals
Number of subjects: 410
Study 32001256 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-Beall journals
Number of subjects: 410
Study 32001256 — intervention group
Group type: EXPERIMENTAL
Intervention: PubMed indexed journals
Number of subjects: 410
Study 32001256 — intervention group
Group type: COMPARATOR
Intervention: Nonindexed journals
Number of subjects: 410
Study 35548481 — intervention group
Group type: EXPERIMENTAL
Intervention: Music intervention applied to the observation group
Number of subjects: 96
Study 35548481 — intervention group
Group type: COMPARATOR
Intervention: No music intervention applied to the control group
Number of subjects: 96
Study 33736679 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI
Number of subjects: 836
Study 33736679 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound
Number of subjects: 836
Study 33115898 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored intervention group (TG) receiving healthy eating messages based on their stage of change.
Number of subjects: 390
Study 33115898 — intervention group
Group type: EXPERIMENTAL
Intervention: General intervention group (GG) receiving the same healthy eating messages based on the Brazilian food guide.
Number of subjects: 390
Study 33115898 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG) receiving messages on a different theme.
Number of subjects: 390
Study 34275444 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 cigarettes per pack (intervention)
Number of subjects: 124
Study 34275444 — intervention group
Group type: COMPARATOR
Intervention: Usual packs (control)
Number of subjects: 124
Study 35666235 — intervention group
Group type: EXPERIMENTAL
Intervention: Video-based game exercise group (VGEG)
Number of subjects: 45
Study 35666235 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured closed kinetic chain exercise group (CKCEG)
Number of subjects: 45
Study 35666235 — intervention group
Group type: COMPARATOR
Intervention: Conventional exercise group (CEG)
Number of subjects: 45
Study 35264220 — intervention group
Group type: EXPERIMENTAL
Intervention: Reading a book in bed
Number of subjects: 991
Study 35264220 — intervention group
Group type: COMPARATOR
Intervention: Not reading a book in bed
Number of subjects: 991
Study 32252103 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-joint (MJ) exercises
Number of subjects: 30
Study 32252103 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-joint (SJ) exercises
Number of subjects: 30
Study 32252103 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of multi-joint and single-joint (MJ+SJ) exercises
Number of subjects: 30
Study 32252103 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (MJ, SJ, MJ+SJ)
Number of subjects: 30
Study 32252103 — intervention group
Group type: EXPERIMENTAL
Intervention: MJ and MJ+SJ groups
Number of subjects: 30
Study 34986506 — intervention group
Group type: EXPERIMENTAL
Intervention: SQ sublingual immunotherapy tablets for grass pollen allergy
Number of subjects: 514
Study 34986506 — intervention group
Group type: EXPERIMENTAL
Intervention: SQ sublingual immunotherapy tablets for tree pollen allergy
Number of subjects: 514
Study 34619982 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovascular intervention
Number of subjects: 64
Study 34112032 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-management support intervention
Number of subjects: 388
Study 34112032 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 388
Study 34507584 — intervention group
Group type: EXPERIMENTAL
Intervention: Parenting for Lifelong Health (PLH) intervention
Number of subjects: 552
Study 34507584 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 552
Study 34000386 — intervention group
Group type: EXPERIMENTAL
Intervention: Identical summary statistics in randomized controlled trials (RCT)
Number of subjects: 0
Study 34000386 — intervention group
Group type: EXPERIMENTAL
Intervention: Identical summary statistics in clinical cohorts
Number of subjects: 0
Study 34000386 — intervention group
Group type: COMPARATOR
Intervention: Control datasets
Number of subjects: 0
Study 34752971 — intervention group
Group type: EXPERIMENTAL
Intervention: Hand grip strength dependence on hand size
Number of subjects: 0
Study 34752971 — intervention group
Group type: EXPERIMENTAL
Intervention: Hand grip strength dependence on wrist thickness
Number of subjects: 0
Study 33652127 — intervention group
Group type: EXPERIMENTAL
Intervention: Rehabilitation Transition Plan (RTP) - includes Rehabilitation Discharge Plan (RDP) plus individualized, manualized care management via phone or videoconference for 6 months.
Number of subjects: 900
Study 33652127 — intervention group
Group type: COMPARATOR
Intervention: Rehabilitation Discharge Plan (RDP) - includes patient/family education and referrals for continued care.
Number of subjects: 900
Study 35249833 — intervention group
Group type: EXPERIMENTAL
Intervention: Erector spinae plane block (ESPB)
Number of subjects: 0
Study 35249833 — intervention group
Group type: COMPARATOR
Intervention: Combined deep and superficial serratus anterior plane block (C‐SAPB)
Number of subjects: 0
Study 33496413 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (0.5 mg / kg / h)
Number of subjects: 60
Study 33496413 — intervention group
Group type: COMPARATOR
Intervention: Remifentanil (50‐100 μg / kg / h)
Number of subjects: 60
Study 33496413 — intervention group
Group type: EXPERIMENTAL
Intervention: Both Dexmedetomidine and Remifentanil
Number of subjects: 60
Study 32805184 — intervention group
Group type: EXPERIMENTAL
Intervention: Statin+high‐dose EPA (1800 mg/day)
Number of subjects: 130
Study 32805184 — intervention group
Group type: EXPERIMENTAL
Intervention: Statin+EPA (930 mg/day)+DHA (750 mg/day)
Number of subjects: 130
Study 32805184 — intervention group
Group type: COMPARATOR
Intervention: Statin only (control group)
Number of subjects: 130
Study 36174630 — intervention group
Group type: EXPERIMENTAL
Intervention: Olaparib plus abiraterone
Number of subjects: 0
Study 36174630 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus abiraterone
Number of subjects: 0
Study 36052819 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal tDCS to the left dlPFC
Number of subjects: 29
Study 36052819 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 29
Study 34755785 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen/Caffeine
Number of subjects: 84
Study 34755785 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 84
Study 32313031 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT) followed by Resistance Training (RT) for 12 weeks each (n=9)
Number of subjects: 17
Study 32313031 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance Training (RT) following High-Intensity Interval Training (HIIT) for 12 weeks (n=9)
Number of subjects: 17
Study 32313031 — intervention group
Group type: COMPARATOR
Intervention: Resistance Training (RT) following Habitual Course Observation (HC) for 12 weeks (n=8)
Number of subjects: 17
Study 33549795 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance exercise (R) - 2 sets of 10 reps in eight resistance exercises
Number of subjects: 12
Study 33549795 — intervention group
Group type: COMPARATOR
Intervention: Walking exercise (W) - 10 bouts of 2‐min walking at the speed corresponding to the onset of claudication pain with 2‐min interval among sets
Number of subjects: 12
Study 33549795 — intervention group
Group type: COMPARATOR
Intervention: Combined exercise (CO) - 1 set of 10 reps in eight resistance exercises + 5 bouts of 2‐min walking with 2‐min interval between
Number of subjects: 12
Study 33549795 — intervention group
Group type: COMPARATOR
Intervention: Control session (C) - resting in exercise room
Number of subjects: 12
Study 35272897 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraosseous morphine (10 mg) with standard IO antibiotic injection
Number of subjects: 48
Study 35272897 — intervention group
Group type: COMPARATOR
Intervention: Control group received standard IO antibiotic injection
Number of subjects: 48
Study 33238907 — intervention group
Group type: EXPERIMENTAL
Intervention: Collaborative infertility counseling (CIC) program, five sessions
Number of subjects: 60
Study 33238907 — intervention group
Group type: COMPARATOR
Intervention: Control group (usual care)
Number of subjects: 60
Study 32198515 — intervention group
Group type: EXPERIMENTAL
Intervention: CYD-TDV
Number of subjects: 3927
Study 32198515 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3927
Study 33028305 — intervention group
Group type: EXPERIMENTAL
Intervention: Engagement with faith communities to address violence against women and girls (VAWG)
Number of subjects: 1949
Study 33028305 — intervention group
Group type: EXPERIMENTAL
Intervention: Engagement with faith communities to address VAWG
Number of subjects: 1949
Study 35312749 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Number of subjects: 0
Study 33655437 — intervention group
Group type: EXPERIMENTAL
Intervention: XP-endo Shaper (XPS)
Number of subjects: 16
Study 33655437 — intervention group
Group type: COMPARATOR
Intervention: ProTaper Next (PTN)
Number of subjects: 16
Study 33452434 — intervention group
Group type: EXPERIMENTAL
Intervention: Active tDCS
Number of subjects: 43
Study 33452434 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 43
Study 33244562 — intervention group
Group type: EXPERIMENTAL
Intervention: MCP® BCMC® strains (administered twice daily)
Number of subjects: 0
Study 33244562 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 36447221 — intervention group
Group type: EXPERIMENTAL
Intervention: Renal replacement therapy (RRT)
Number of subjects: 287
Study 36447221 — intervention group
Group type: EXPERIMENTAL
Intervention: Duration of RRT
Number of subjects: 287
Study 36447221 — intervention group
Group type: EXPERIMENTAL
Intervention: SOFA score at initiation of RRT
Number of subjects: 287
Study 33539946 — intervention group
Group type: EXPERIMENTAL
Intervention: Nivolumab 240 mg every 2 weeks
Number of subjects: 569
Study 33539946 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy (topotecan or amrubicin)
Number of subjects: 569
Study 33168839 — intervention group
Group type: EXPERIMENTAL
Intervention: Laxative immediately followed by Clostridium butyricum (CB) administration for 2 weeks (LP)
Number of subjects: 0
Study 33168839 — intervention group
Group type: EXPERIMENTAL
Intervention: Laxative, interval of 2 weeks and CB administration for 2 weeks (L2P)
Number of subjects: 0
Study 33168839 — intervention group
Group type: EXPERIMENTAL
Intervention: CB administration for 2 weeks (P)
Number of subjects: 0
Study 35168256 — intervention group
Group type: EXPERIMENTAL
Intervention: Invisalign aligners with SmartForce features and attachments
Number of subjects: 66
Study 35168256 — intervention group
Group type: COMPARATOR
Intervention: Traditional fixed appliances (braces)
Number of subjects: 66
Study 35168256 — intervention group
Group type: EXPERIMENTAL
Intervention: Posttreatment changes in aligner group
Number of subjects: 66
Study 35168256 — intervention group
Group type: COMPARATOR
Intervention: Posttreatment changes in braces group
Number of subjects: 66
Study 35168256 — intervention group
Group type: EXPERIMENTAL
Intervention: Total OGS scores posttreatment
Number of subjects: 66
Study 34310744 — intervention group
Group type: EXPERIMENTAL
Intervention: Dopamine
Number of subjects: 98
Study 34310744 — intervention group
Group type: COMPARATOR
Intervention: Norepinephrine
Number of subjects: 98
Study 35378633 — intervention group
Group type: EXPERIMENTAL
Intervention: Lumentin® 44 (L44)
Number of subjects: 45
Study 35378633 — intervention group
Group type: COMPARATOR
Intervention: Diluted Omnipaque®
Number of subjects: 45
Study 35378633 — intervention group
Group type: COMPARATOR
Intervention: MoviPrep®
Number of subjects: 45
Study 33463027 — intervention group
Group type: EXPERIMENTAL
Intervention: 10‐kHz spinal cord stimulation (SCS) plus conventional medical management (CMM)
Number of subjects: 211
Study 33463027 — intervention group
Group type: COMPARATOR
Intervention: Conventional medical management (CMM) alone
Number of subjects: 211
Study 33234645 — intervention group
Group type: EXPERIMENTAL
Intervention: Azathioprine
Number of subjects: 60
Study 33234645 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 33728530 — intervention group
Group type: EXPERIMENTAL
Intervention: Planned discharge education
Number of subjects: 100
Study 33728530 — intervention group
Group type: COMPARATOR
Intervention: Control group (no planned discharge education)
Number of subjects: 100
Study 33821332 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (8000 IU daily)
Number of subjects: 39
Study 33821332 — intervention group
Group type: COMPARATOR
Intervention: Placebo supplementation
Number of subjects: 39
Study 34618364 — intervention group
Group type: EXPERIMENTAL
Intervention: Transobturator autologous rectus fascial sling (TO-AFS)
Number of subjects: 132
Study 34618364 — intervention group
Group type: COMPARATOR
Intervention: Transobturator tension-free vaginal tape (TVT-O)
Number of subjects: 132
Study 33761932 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy of transcranial pulsed current stimulation (tPCS) at 400 Hz, 1 mA and transcutaneous electrical nerve stimulation (TENS) at 400 Hz, max 10 mA for 30 min, followed by 30 min of physiotherapy five times per week for 12 weeks.
Number of subjects: 63
Study 33761932 — intervention group
Group type: COMPARATOR
Intervention: Physiotherapy only for 30 mins per day five times per week for 12 weeks.
Number of subjects: 63
Study 32580655 — intervention group
Group type: EXPERIMENTAL
Intervention: Ivabradine
Number of subjects: 6505
Study 32580655 — intervention group
Group type: COMPARATOR
Intervention: Central End Point Committee (CEC) adjudication
Number of subjects: 6505
Study 32580655 — intervention group
Group type: EXPERIMENTAL
Intervention: Investigators
Number of subjects: 6505
Study 35403245 — intervention group
Group type: COMPARATOR
Intervention: Veliparib monotherapy (300-400 mg twice daily)
Number of subjects: 0
Study 35403245 — intervention group
Group type: COMPARATOR
Intervention: Veliparib in combination with carboplatin/paclitaxel (120 mg twice daily)
Number of subjects: 0
Study 35403245 — intervention group
Group type: EXPERIMENTAL
Intervention: Veliparib exposure as a time-varying predictor
Number of subjects: 0
Study 35403245 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure-safety analysis
Number of subjects: 0
Study 33237904 — intervention group
Group type: EXPERIMENTAL
Intervention: Systolic BP in Swedish cohorts
Number of subjects: 215274
Study 33237904 — intervention group
Group type: EXPERIMENTAL
Intervention: Mendelian Randomization analysis in Swedish cohorts
Number of subjects: 215274
Study 33237904 — intervention group
Group type: EXPERIMENTAL
Intervention: Systolic BP in UK-biobank
Number of subjects: 215274
Study 33237904 — intervention group
Group type: EXPERIMENTAL
Intervention: Systolic BP for muscle-invasive bladder cancer (MIBC) in Swedish cohorts
Number of subjects: 215274
Study 33237904 — intervention group
Group type: EXPERIMENTAL
Intervention: Diastolic BP for muscle-invasive bladder cancer (MIBC) in Swedish cohorts
Number of subjects: 215274
Study 33237904 — intervention group
Group type: COMPARATOR
Intervention: Interaction between BP and NAT2
Number of subjects: 215274
Study 32357807 — intervention group
Group type: EXPERIMENTAL
Intervention: Out of pocket expenses reported by participants with OCD
Number of subjects: 465
Study 35490579 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-reported physical well-being
Number of subjects: 2894
Study 35490579 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-reported functional well-being
Number of subjects: 2894
Study 35490579 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-reported breast cancer subscale
Number of subjects: 2894
Study 35490579 — intervention group
Group type: COMPARATOR
Intervention: ECOG PS
Number of subjects: 2894
Study 32459724 — intervention group
Group type: EXPERIMENTAL
Intervention: AttraX Putty
Number of subjects: 100
Study 32459724 — intervention group
Group type: COMPARATOR
Intervention: Autograft
Number of subjects: 100
Study 35809704 — intervention group
Group type: EXPERIMENTAL
Intervention: β‐caryophyllene (100 mg/daily with meal)
Number of subjects: 26
Study 35809704 — intervention group
Group type: EXPERIMENTAL
Intervention: β‐caryophyllene
Number of subjects: 26
Study 35809704 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study 34782532 — intervention group
Group type: EXPERIMENTAL
Intervention: Ferrous ascorbate (FeA)
Number of subjects: 0
Study 34782532 — intervention group
Group type: COMPARATOR
Intervention: Ferrous sulphate (FS)
Number of subjects: 0
Study 34782532 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron hydroxide polymaltose complex (IPC)
Number of subjects: 0
Study 32535732 — intervention group
Group type: EXPERIMENTAL
Intervention: IL-6 inhibitors (tocilizumab, sarilumab, siltuximab)
Number of subjects: 0
Study 32535732 — intervention group
Group type: EXPERIMENTAL
Intervention: IL-6 inhibitors (tocilizumab, sarilumab)
Number of subjects: 0
Study 32535732 — intervention group
Group type: EXPERIMENTAL
Intervention: IL-6 inhibitors
Number of subjects: 0
Study 36220198 — intervention group
Group type: EXPERIMENTAL
Intervention: Incentivized lifestyle intervention program with stepwise addition of metformin
Number of subjects: 751
Study 36220198 — intervention group
Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 751
Study 33471963 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone-delivered adherence therapy (8 weekly 30-min sessions)
Number of subjects: 40
Study 33471963 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 40
Study 36106493 — intervention group
Group type: COMPARATOR
Intervention: Intranasal isotonic saline (Group C)
Number of subjects: 318
Study 36106493 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal dexmedetomidine 0.5 μg kg-1 (Group D0.5)
Number of subjects: 318
Study 36106493 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal dexmedetomidine 1.0 μg kg-1 (Group D1.0)
Number of subjects: 318
Study 36106493 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal dexmedetomidine 1.5 μg kg-1 (Group D1.5)
Number of subjects: 318
Study 36106493 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal dexmedetomidine 2.0 μg kg-1 (Group D2.0)
Number of subjects: 318
Study 36106493 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal dexmedetomidine (ED95)
Number of subjects: 318
Study 32145115 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified health assessment
Number of subjects: 40
Study 32145115 — intervention group
Group type: COMPARATOR
Intervention: Management errors in calculated growth rates
Number of subjects: 40
Study 33818305 — intervention group
Group type: EXPERIMENTAL
Intervention: nCBT
Number of subjects: 56
Study 33818305 — intervention group
Group type: COMPARATOR
Intervention: WL
Number of subjects: 56
Study 33077128 — intervention group
Group type: EXPERIMENTAL
Intervention: Bovine colostrum (BC) supplementation
Number of subjects: 10
Study 33077128 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 10
Study 33077128 — intervention group
Group type: EXPERIMENTAL
Intervention: Bovine colostrum (BC)
Number of subjects: 10
Study 33077128 — intervention group
Group type: EXPERIMENTAL
Intervention: Bovine colostrum (BC) and Placebo (PLA)
Number of subjects: 10
Study 34225282 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical nerve stimulation (TENS) applied for 30 mins once a day for 90 days
Number of subjects: 83
Study 34225282 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical nerve stimulation (TENS)
Number of subjects: 83
Study 34225282 — intervention group
Group type: COMPARATOR
Intervention: Control group continued to receive anticholinergic drugs for 90 days
Number of subjects: 83